Intra-Cellular Therapies Inc. (ITCI) Narx-foyda multiplikatori
Intra-Cellular Therapies (ITCI) barqaror pul oqimlarini ta'minlovchi bipolar buzilish va shizofreniya terapiyalaridan tushadigan bashorat qilinadigan daromadlarga tayanadi. Kompaniyaning raqobatbardoshlik afzalliklari mustahkam patent himoyasi va professional psixiatriya hamjamiyati tomonidan tan olinganligi bilan kafolatlangan. GURU.Markets platformasidagi ushbu narxlar grafigi asosiy dori vositasining sotuvidan olingan foydaning keskin o'sishi va investorlarning yuqori kutuvlari natijasida shakllangan -185.50 miqdoridagi PE ko'rsatkichini ko'rsatmoqda.
Intra-Cellular Therapies Inc. (ITCI) kompaniyasining tahliliy kesimlari
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Intra-Cellular Therapies|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning o'z kapitaliga nisbati Intra-Cellular|ITCI - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Intra-Cellular Therapies, Inc.|ITCI - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Intra-Cellular Therapies|Tezkor likvidlik intracellulartherapies.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ITCI - Kompaniyaning sof foydasi|Kutilayotgan foyda Intra-Cellular Therapies|ITCI - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Intra-Cellular|ITCI - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Intra-Cellular Therapies, Inc.|ITCI - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Intra-Cellular Therapies|ITCI - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi intracellulartherapies.com|ITCI - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Intra-Cellular Therapies
Kompaniyaning jamlanma tahlili:ITCI intracellulartherapies.com
Ushbu ko'rsatkich bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadi va biznes qiymatining operatsion samaradorlikka sezgirligini aks ettiradi. Ushbu nisbat joriy rentabellik asosida investitsiyalarning qoplanish muddatini o'lchaydi. Intra-Cellular Therapies (ITCI) uchun bu ko'rsatkich Caplyta tijorat sotuvlari va tartibga soluvchi narx cheklovlariga kritik darajada bog'liq. Patent risklari natijasida yuzaga keladigan har qanday marja qisqarishi baholashda zudlik bilan aks etadi. Joriy P/E ko'paytirgichini tahlil qilish orqali investor fundamental past baholanganlikni tushumning tizimli pasayishidan ajratib olishi mumkin.
Muhim raqobatchilar
biogen.com (BIIB) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|Regencell Bioscience Ltd - Narx-foyda multiplikatori|Axsome Therapeutics Inc - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACAD (ACADIA Corp)|XENE - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati VKTX (vikingtherapeutics.com)|SUPN: P/E multiplikatori|Catalyst Pharma (CPRX) - P/E multiplikatori|Narx-foyda koeffitsiyenti DNLI|HRMY - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori BHVN|Narx-foyda koeffitsiyenti amylyx.com AMLX|P/E multiplikatori TRVI (Trevi Therapeutics, Inc.)|Praxis Precision Medicines Inc (PRAX) - Kapitalizatsiyaning foydaga nisbati|AVXL - Narxning foydaga nisbati|CBLL: Narxning foydaga nisbati|prothena.com (PRTA) - Narxning foydaga nisbati|ALEC (Alector) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti ANNX|P/E multiplikatori Omeros Corp.|Narxning foydaga nisbati Neurogene Corp (NGNE)|Narxning foydaga nisbati ACIU (AC Immune Inc)|P/E multiplikatori VYGR (Voyager Therapeutics)|P/E multiplikatori neumoratx.com NMRA|SCLX - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TVGN (Tevogen Bio Holdings Inc.)|ACOG (alphacognition.com) - Narx-foyda koeffitsiyenti|Cognition Therapeutics Inc. - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti IKT|SAVA (cassavasciences.com) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ASRT|COYA (coyatherapeutics.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalizatsiyaning foydaga nisbati|ABOS - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CRVO (cervomed.com)|ATHE: P/E multiplikatori|Clene (CLNN) - P/E multiplikatori|Narxning foydaga nisbati PepGen Inc|Jupiter Neurosciences, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RLMD|Biznesning o‘zini qoplash muddati annovisbio.com|P/E multiplikatori GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Kapitalizatsiyaning foydaga nisbati|KLTO - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati NeuroSense Therapeutics NRSN|RVPH: P/E multiplikatori|MTVA - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NRXS|HSDT (Helius Medical Technologies Inc.) - Bozor narxining sof foydaga nisbati|P/E multiplikatori PASG|Narx-foyda koeffitsiyenti bionomics.com.au NEUP|P/E multiplikatori NERV (Minerva Neurosciences)|Biznesning o‘zini qoplash muddati athira.com (ATHA)|ADXN - Narxning foydaga nisbati|ALZN (Alzamend Neuro, Inc.) - Narx-foyda multiplikatori|CYCN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Protagenic Therapeutics, Inc. (PTIX)|Narx-foyda koeffitsiyenti KTTA|P/E multiplikatori Cortigent Medical|Narxning foydaga nisbati Avenue Therapeutics, Inc. (ATXI)|BCLI (Brainstorm Cell Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Cara Therapeutics, Inc CARA|Chromocell (CHRO) - Kapitalizatsiyaning foydaga nisbati|Eliem - P/E multiplikatori|Biznesning o‘zini qoplash muddati longboardpharma.com LBPH|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|Narx-foyda multiplikatori NKGN|Narx-foyda koeffitsiyenti NRBO|SAGE (Sage Therapeutics Inc) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Synaptogenix, Inc. (SNPX)|TRVN (trevena.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|P/E multiplikatori anewmeds.com WENA|CERE: Narx-foyda koeffitsiyenti
